144 related articles for article (PubMed ID: 38280018)
41. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous detection of high-sensitivity cardiac troponin I and myoglobin by modified sandwich lateral flow immunoassay: proof of principle.
Zhu J; Zou N; Zhu D; Wang J; Jin Q; Zhao J; Mao H
Clin Chem; 2011 Dec; 57(12):1732-8. PubMed ID: 21998340
[TBL] [Abstract][Full Text] [Related]
43. Sensitive and rapid determination of heat shock protein 70 using lateral flow immunostrips and upconversion nanoparticle fluorescence probes.
Wu N; Wei Y; Pan L; Yang X; Qi H; Gao Q; Zhang C; Li CZ
Analyst; 2022 Jul; 147(15):3444-3450. PubMed ID: 35792747
[TBL] [Abstract][Full Text] [Related]
44. Analytical evaluation of an automated immunoassay for cardiac troponin I: the Vidas Troponin I assay.
Di Serio F; Trerotoli P; Serio G; Varraso L; Pansini N
Clin Chem Lab Med; 2003 Oct; 41(10):1363-8. PubMed ID: 14580167
[TBL] [Abstract][Full Text] [Related]
45. One-pot synthesis of AuPt@Fe
Wang H; Yao C; Fan J; He Y; Wang Z
Biosens Bioelectron; 2023 Oct; 237():115508. PubMed ID: 37442031
[TBL] [Abstract][Full Text] [Related]
46. Improving sensitivity of gold nanoparticle-based lateral flow assays by using wax-printed pillars as delay barriers of microfluidics.
Rivas L; Medina-Sánchez M; de la Escosura-Muñiz A; Merkoçi A
Lab Chip; 2014 Nov; 14(22):4406-14. PubMed ID: 25241662
[TBL] [Abstract][Full Text] [Related]
47. Immunoassay of goat antihuman immunoglobulin G antibody based on luminescence resonance energy transfer between near-infrared responsive NaYF4:Yb, Er upconversion fluorescent nanoparticles and gold nanoparticles.
Wang M; Hou W; Mi CC; Wang WX; Xu ZR; Teng HH; Mao CB; Xu SK
Anal Chem; 2009 Nov; 81(21):8783-9. PubMed ID: 19807113
[TBL] [Abstract][Full Text] [Related]
48. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
[TBL] [Abstract][Full Text] [Related]
49. A comparison of capture antibody fragments in cardiac troponin I immunoassay.
Hyytiä H; Järvenpää ML; Ristiniemi N; Lövgren T; Pettersson K
Clin Biochem; 2013 Aug; 46(12):963-968. PubMed ID: 23370114
[TBL] [Abstract][Full Text] [Related]
50. Development of an Electrochemical Immunosensor for Detection of Cardiac Troponin I at the Point-of-Care.
Lee TH; Chen LC; Wang E; Wang CC; Lin YR; Chen WL
Biosensors (Basel); 2021 Jun; 11(7):. PubMed ID: 34206922
[TBL] [Abstract][Full Text] [Related]
51. Ultrasensitive chemiluminescence immunoassay with enhanced precision for the detection of cTnI amplified by acridinium ester-loaded microspheres and internally calibrated by magnetic fluorescent nanoparticles.
Zhao H; Lin Q; Huang L; Zhai Y; Liu Y; Deng Y; Su E; He N
Nanoscale; 2021 Feb; 13(5):3275-3284. PubMed ID: 33533772
[TBL] [Abstract][Full Text] [Related]
52. Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction.
Aldous S; Mark Richards A; George PM; Cullen L; Parsonage WA; Flaws D; Florkowski CM; Troughton RW; O'Sullivan JW; Reid CM; Bannister L; Than M
Int J Cardiol; 2014 Nov; 177(1):182-6. PubMed ID: 25499373
[TBL] [Abstract][Full Text] [Related]
53. High performance immunochromatographic assay for simultaneous quantitative detection of multiplex cardiac markers based on magnetic nanobeads.
Hong L; Wang K; Yan W; Xu H; Chen Q; Zhang Y; Cui D; Jin Q; He J
Theranostics; 2018; 8(22):6121-6131. PubMed ID: 30613287
[TBL] [Abstract][Full Text] [Related]
54. Upconversion fluorescence immunoassay for imidaclothiz by magnetic nanoparticle separation.
Hua X; You H; Luo P; Tao Z; Chen H; Liu F; Wang M
Anal Bioanal Chem; 2017 Nov; 409(29):6885-6892. PubMed ID: 28975377
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in sensitive surface-enhanced Raman scattering-based lateral flow assay platforms for point-of-care diagnostics of infectious diseases.
Kim K; Kashefi-Kheyrabadi L; Joung Y; Kim K; Dang H; Chavan SG; Lee MH; Choo J
Sens Actuators B Chem; 2021 Feb; 329():129214. PubMed ID: 36568647
[TBL] [Abstract][Full Text] [Related]
56. A novel carboxyl polymer-modified upconversion luminescent nanoprobe for detection of prostate-specific antigen in the clinical gray zonebase by flow immunoassay strip.
Hu X; Liao J; Shan H; He H; Du Z; Guan M; Hu J; Li J; Gu B
Methods; 2023 Jul; 215():10-16. PubMed ID: 37169320
[TBL] [Abstract][Full Text] [Related]
57. Analytical performance comparing siemens whole blood point of care Atellica VTLi to the central laboratory plasma Atellica IM high-sensitivity cardiac troponin I assays.
Xiong-Hang K; Schulz K; Sandoval Y; Smith SW; Saenger AK; Apple FS
Clin Biochem; 2023 Apr; 114():79-85. PubMed ID: 36780933
[TBL] [Abstract][Full Text] [Related]
58. Antibody coated conductive polymer for the electrochemical immunosensing of Human Cardiac Troponin I in blood plasma.
Gholami MD; O'Mullane AP; Sonar P; Ayoko GA; Izake EL
Anal Chim Acta; 2021 Nov; 1185():339082. PubMed ID: 34711328
[TBL] [Abstract][Full Text] [Related]
59. A graphene oxide/gold nanoparticle-based amplification method for SERS immunoassay of cardiac troponin I.
Fu X; Wang Y; Liu Y; Liu H; Fu L; Wen J; Li J; Wei P; Chen L
Analyst; 2019 Feb; 144(5):1582-1589. PubMed ID: 30666995
[TBL] [Abstract][Full Text] [Related]
60. Microparticle-based platform for point-of-care immunoassays.
Salminen T; Juntunen E; Lahdenranta M; Martiskainen I; Talha SM; Pettersson K
Anal Biochem; 2018 May; 548():66-68. PubMed ID: 29486205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
